APA

Shahbazian H., Zafar Mohtashami A., Ghorbani A., Abbaspour M. R., Belladi Musavi S. S., Hayati F. & Lashkarara G. R. (20110809). Oral nicotinamide reduces serum phosphorus, increases HDL, and induces thrombocytopenia in hemodialysis patients: a double-blind randomized clinical trial. : Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Chicago

Shahbazian Heshmatolah, Zafar Mohtashami Azita, Ghorbani Ali, Abbaspour Mohammad Reza, Belladi Musavi Sayed Seifolah, Hayati Fatemeh and Lashkarara Ghollam Reza. 20110809. Oral nicotinamide reduces serum phosphorus, increases HDL, and induces thrombocytopenia in hemodialysis patients: a double-blind randomized clinical trial. : Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Harvard

Shahbazian H., Zafar Mohtashami A., Ghorbani A., Abbaspour M. R., Belladi Musavi S. S., Hayati F. and Lashkarara G. R. (20110809). Oral nicotinamide reduces serum phosphorus, increases HDL, and induces thrombocytopenia in hemodialysis patients: a double-blind randomized clinical trial. : Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

MLA

Shahbazian Heshmatolah, Zafar Mohtashami Azita, Ghorbani Ali, Abbaspour Mohammad Reza, Belladi Musavi Sayed Seifolah, Hayati Fatemeh and Lashkarara Ghollam Reza. Oral nicotinamide reduces serum phosphorus, increases HDL, and induces thrombocytopenia in hemodialysis patients: a double-blind randomized clinical trial. : Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 20110809.